A peptide that inhibits virus transmission among ferrets may point to a promising treatment

February 17, 2021

An engineered peptide given to ferrets two days before they were co-housed with SARS-CoV-2-infected animals prevented virus transmission to the treated ferrets, a new study shows. The peptides used are highly stable and thus have the potential to translate into effective intranasal prophylaxis to reduce infection and severe SARS-CoV-2 disease in humans, the study's authors say. The SARS-CoV-2 spike (S) protein binds to host cells to initiate infection. This stage in the virus life history is a target for drug inhibition. Here, researchers with past success designing lipopeptide fusion inhibitors that block this critical first step of infection for SARS-CoV-2 and other viruses sought to design a SARS-CoV-2-specific inhibitor that was highly potent. Testing various designs in cell culture, Rory D. de Vries and colleagues identified one particularly effective lipopeptide against SARS-CoV-2, which also inhibited binding by emerging SARS-CoV-2 variants, including B.1.1.7 and B.1.351. In further studies of this candidate in the lungs of humanized mice, it persisted in the respiratory tract, a sign that it can protect against virus replication. To test the ability of their leading inhibitor candidate to block viral transmission, the researchers turned to ferrets, a model for evaluating airborne virus spread (although ferrets do not display strong clinical symptoms after infection). Some ferrets in the authors' study were dosed with the peptide before being co-housed with SARS-CoV-2-infected ferrets for 24 hours; other ferrets weren't. After this 24-hour period, SARS-CoV-2 was not detected in the throats or noses of any treated ferrets, while infectious virus was detected in all untreated ferrets. In further experiments with ferrets, the authors show that administration of the peptide intranasally just two hours before exposure delayed infection. They say their intranasal peptide offers "successful prophylaxis that prevents SARS-CoV-2 transmission in a relevant animal model" and "should readily translate into a safe and effective nasal spray or inhalation administered fusion inhibitor for SARS-CoV-2 prophylaxis." They also note that a combination of drugs that target different aspects of the viral life cycle would likely be best-suited for SARS-CoV-2.
-end-


American Association for the Advancement of Science

Related Infection Articles from Brightsurf:

Halving the risk of infection following surgery
New analysis by the University of Leeds and the University of Bern of more than 14,000 operations has found that using alcoholic chlorhexidine gluconate (CHG) halves the risk of infection in certain types of surgery when compared to the more commonly used povidone-iodine (PVI).

How plants shut the door on infection
A new study by an international team including University of Maryland scientists has discovered the key calcium channel responsible for closing plant pores as an immune response to pathogen exposure.

Sensing infection, suppressing regeneration
UIC researchers describe an enzyme that blocks the ability of blood vessel cells to self-heal.

Boost to lung immunity following infection
The strength of the immune system in response to respiratory infections is constantly changing, depending on the history of previous, unrelated infections, according to new research from the Crick.

Is infection after surgery associated with increased long-term risk of infection, death?
Whether experiencing an infection within the first 30 days after surgery is associated with an increased risk of another infection and death within one year was the focus of this observational study that included about 660,000 veterans who underwent major surgery.

Revealed: How E. coli knows how to cause the worst possible infection
The discovery could one day let doctors prevent the infection by allowing E. coli to pass harmlessly through the body.

UK study shows most patients with suspected urinary tract infection and treated with antibiotics actually lack evidence of this infection
New research presented at this week's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Amsterdam, Netherlands (April 13-16, 2019) shows that only one third of patients that enter the emergency department with suspected urinary tract infection (UTI) actually have evidence of this infection, yet almost all are treated with antibiotics, unnecessarily driving the emergence of antimicrobial resistance.

Bacteria in urine doesn't always indicate infection
Doctors should think carefully before testing patients for a urinary tract infection (UTI) to avoid over-diagnosis and unnecessary antibiotic treatment, according to updated asymptomatic bacteriuria (ASB) guidelines released by the Infectious Diseases Society of America (IDSA) and published in Clinical Infectious Diseases.

Subsidies for infection control to healthcare institutions help reduce infection levels
Researchers compared three types of infection control subsidies and found that under a limited budget, a dollar-for-dollar matching subsidy, in which policymakers match hospital spending for infection control measures, was the most effective at reducing the number of hospital-acquired infections.

Dengue virus infection may cause severe outcomes following Zika virus infection during pregnancy
This study is the first to report a possible mechanism for the enhancement of Zika virus progression during pregnancy in an animal model.

Read More: Infection News and Infection Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.